Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/165
Title: | Effects of insulin-like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: Comparison with growth hormone replacement | Authors: | Jevđović, Tanja Maake, C. Eppler, E. Zoidis, E. Reinecke, M. Zapf, Juergen |
Issue Date: | 1-Aug-2004 | Journal: | European Journal of Endocrinology | Abstract: | Background: In GH-deficient humans, GH and IGF-I treatment cause opposite effects on serum insulin concentrations and insulin sensitivity. This finding contrasts with the somatomedin hypothesis that IGF-I mediates GH action, as postulated for skeletal growth, and raises the question whether GH-induced IGF-I acts on the endocrine pancreas in the same way as administered IGF-I. Objective: To compare the effects of the two hormones on the endocrine pancreas of hypophysectomized rats. Methods: Animals were infused for 2 days, via miniosmotic pumps, with IGF-I (300 μg/day), GH (200 mU/day) or vehicle. We measured (i) glucose, IGF-I, insulin, C-peptide and glucagon in serum and (ii) IGF-I, insulin and glucagon mRNAs and peptides in the pancreas by radioimmunoassay, immunohistochemistry and northern analysis. Results: Both GH end IGF-I treatment increased serum and pancreatic IGF-I but, unlike GH, IGF-I treatment strongly reduced serum insulin and C-peptide (and, to a lesser extent, serum glucagon). Nevertheless, the animals did not become hyperglycaemic. GH, but not IGF-I, increased pancreatic insulin and glucagon content, as also indicated by immunohistochemistry, and increased IGF-I mRNA. Neither GH nor IGF-I caused significant changes in insulin and glucagon mRNA. Conclusions: The decrease in serum insulin and C-peptide by IGF-I treatment without significant changes in insulin gene expression and pancreatic insulin content suggests inhibition of insulin secretion. Within this setting, the absence of hyperglycaemia points to enhanced insulin sensitivity, although an insulin-like action of infused IGF-I may have partially compensated for the decreased insulin concentrations. GH-induced circulating or pancreatic IGF-I, or both, does not mimic the pancreatic effects of infused IGF-I in the absence of GH, suggesting that GH may counteract the action of GH-induced IGF-I on the endocrine pancreas. |
URI: | https://biore.bio.bg.ac.rs/handle/123456789/165 | ISSN: | 0804-4643 | DOI: | 10.1530/eje.0.1510223 |
Appears in Collections: | Journal Article |
Show full item record
SCOPUSTM
Citations
6
checked on Nov 1, 2024
Page view(s)
2
checked on Nov 4, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.